Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label study of hbFGF gel for deep partial-thickness burns
CTR20232626Phase 2Active
- Sponsor
- Yaogu (Wenzhou) Technology Development
- Start
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of trafermin in burn injury, sponsored by Yaogu (Wenzhou) Technology Development. Started Dec 2023; status: active.
02
Drugs
trafermin
03
Conditions
burn injury
Beyond the preview
Go deeper on CTR20232626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232626.